APHQF - Aphria Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
8.88
+0.06 (+0.68%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close8.82
Open8.79
Bid0.00 x 0
Ask0.00 x 0
Day's Range8.62 - 8.89
52 Week Range3.97 - 19.87
Volume505,490
Avg. Volume729,863
Market Cap1.874B
Beta3.39
PE Ratio (TTM)56.56
EPS (TTM)0.16
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • This Pot Stock Just Announced the Largest Bought-Deal Financing Ever for the Weed Industry
    Motley Fool2 days ago

    This Pot Stock Just Announced the Largest Bought-Deal Financing Ever for the Weed Industry

    If the over-allotment of stock is purchased, it'll represent a nearly $200 million cash raise.

  • Aphria Appoints Former Southern Glazer's Executive Joel Toguri as Vice President of Sales
    CNW Group3 days ago

    Aphria Appoints Former Southern Glazer's Executive Joel Toguri as Vice President of Sales

    LEAMINGTON, ON , June 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced the appointment of Joel Toguri as Vice President of Sales effective on June 18, 2018 . Mr. Toguri joins the Company from Southern Glazer's of Canada ("Southern Glazer's"), where he was Vice President of Sales and Operations since 2013.

  • 3 Biggest Winners From Canada's Recreational Marijuana Milestone
    Motley Fool7 days ago

    3 Biggest Winners From Canada's Recreational Marijuana Milestone

    Don't worry that most marijuana stocks fell after the big Canadian Senate vote on Thursday. These three stocks should be winners over the long run.

  • Canada's Under-the-Radar Marijuana Supply Problem
    Motley Fool9 days ago

    Canada's Under-the-Radar Marijuana Supply Problem

    It often takes Health Canada a long time to issue cultivation licenses and sales permits.

  • CNW Group9 days ago

    Aphria Welcomes Passage of Bill C-45 in Senate, Ready to Meet Demand for Adult-Use Cannabis in Canada

    Vic Neufeld , CEO of Aphria, said, "Today's passage of Bill C-45 through the Senate is a historic milestone towards safe and legal recreational cannabis in Canada . "While we share the government's goal to create a highly regulated market, we want to ensure that the cannabis industry is well positioned to responsibly meet the needs of Canadians and effectively compete with the black market, which is operating and marketing unbound by ethical or regulatory considerations.

  • Investopedia10 days ago

    10 Canadian Marijuana Stocks for Your Portfolio

    Unlike its southern neighbor, Canada legalized medical marijuana nationwide back in 2001. Further, Canada introduced the Cannabis Act recently and the bill to legalize recreational pot use is expected to pass by July of 2018. Not so in the U.S., where the immediate future for legal weed is in question, after Attorney General Jeff Sessions overturned an Obama-era law that protected states choosing to liberalize legal marijuana laws.

  • Is a Squeeze on the Way for Some Canadian Marijuana Stocks?
    Motley Fool11 days ago

    Is a Squeeze on the Way for Some Canadian Marijuana Stocks?

    Some Canadian marijuana stocks could be in trouble if the predictions of Aphria's CEO come to pass.

  • CNW Group12 days ago

    Aphria to build state-of-the art Extraction Centre of Excellence

    LEAMINGTON, ON , June 6, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that the company's Board of Directors approved a $55 million capital project to build a state-of-the-art Extraction Centre of Excellence in Leamington, ON . Construction of the new Extraction Centre of Excellence is expected to begin immediately and the facility is scheduled to release its first concentrates by March 2019 . Vic Neufeld , CEO of Aphria, said, "The Extraction Centre of Excellence will give Aphria a significant competitive advantage in cannabis concentrates, which are expected to be a significant product category.

  • This Major Marijuana Stock Is Eyeing Africa for Growth Opportunities
    Motley Fool13 days ago

    This Major Marijuana Stock Is Eyeing Africa for Growth Opportunities

    Europe isn't the only export opportunity for this Canadian grower.

  • 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
    Motley Fool16 days ago

    8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production

    The number of major players in Canada's weed industry continues to expand.

  • What Investors Are Paying for Cannabis Sector’s Forward EBITDA
    Market Realist19 days ago

    What Investors Are Paying for Cannabis Sector’s Forward EBITDA

    Similar to what we saw in the previous part of this series, the forward EV-to-EBITDA multiple takes into account the estimates for analysts’ one-year forward EBITDA estimates. Let’s see how this multiple has changed in the past two weeks.

  • 5 Companies Using Tech To Transform The Cannabis Industry
    Oilprice.com20 days ago

    5 Companies Using Tech To Transform The Cannabis Industry

    As Canada prepares to fully legalize recreational marijuana, several companies are harnessing the tremendous power of technology to completely transform the entire industry, earning millions in the process

  • Benzinga20 days ago

    4 Potential Takeout Candidates In The Marijuana Sector

    A consolidation wave is sweeping across the marijuana industry, as companies aim to improve their competitive positioning and market share in an industry which offers a lot a promise. Aurora Cannabis Inc (OTC: ACBFF) recently announced a deal to buy MedReleaf Corp (OTC: MEDFF) in an all-cash transaction valued at C$3.2 billion. The proposed combination would mean a total funded capacity of over 570,000 kg per year of high-quality facilities in Canada and Denmark.

  • CNW Group21 days ago

    Aphria Forms Landmark Venture with South African Company Verve Group of Companies

    The Venture will focus on expanding the Company's footprint in established regulated cannabis markets in Africa . LEAMINGTON, ON , May 28, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a series of agreements (the "Transaction") resulting in Aphria forming a joint venture, CannInvest Africa Ltd. ("CannInvest"), with South African company Verve Group of Companies ("VGC").

  • 3 Marijuana Stocks That Could Be Gobbled Up Next
    Motley Fool21 days ago

    3 Marijuana Stocks That Could Be Gobbled Up Next

    More marijuana acquisitions could be on the way. And these three stocks rank high on the list of buyout candidates.

  • Why SunTrust Raised Price Target for Scotts Miracle-Gro
    Market Realist27 days ago

    Why SunTrust Raised Price Target for Scotts Miracle-Gro

    The Scotts Miracle-Gro Company (SMG) received a recent upgrade from a “buy” to a “hold” from SunTrust Robinson Humphrey. The firm also raised its price target to $100 from $80, saying that the stock will likely see an upside when the hydroponics business takes off on the back of increased cannabis use. The stock had terrible first and second quarter results, and the stock is now 19.5% lower YTD (year-to-date) as of May 16.

  • These Stocks Were the Top Movers in the Cannabis Sector Last Week
    Market Realist27 days ago

    These Stocks Were the Top Movers in the Cannabis Sector Last Week

    Last week, the cannabis sector was broadly positive with the ETF Horizons Marijuana Life Sciences ETF (HMMJ) rising ~4.3%, the Evolve Marijuana ETD (SEED) rising 3%, the ETFMG Alternative Harvest ETF (MJ) rising 1.3%, and the Emerging Marijuana Growers Index ETF (HMJR) rising 0.4% between the close on May 11 and the close on May 18. Over the same period, the TSE 300 Index gained about 1.1%, while the S&P 500 Index fell 0.5%. Let’s look at how some of the cannabis stocks performed last week.

  • How Do Analysts Rate Canaccord Genuity?
    Market Realistlast month

    How Do Analysts Rate Canaccord Genuity?

    On May 16, CannTrust (CNTTF) dropped almost 8.3% on news of further dilution of the stock. The company announced an upsizing of its previously announced offering in which the company will grant its underwriters, Canaccord Genuity and GMP Securities, the option to purchase an additional 1.5 million shares at a price of 9 Canadian dollars. The stock has delivered a loss of 3.2% YTD (year-to-date) but has performed better than industry stocks (MJ) like Aphria (APHQF) and Aurora Cannabis (ACB) (ACBFF).

  • Why Analysts Are Bullish on Aphria
    Market Realistlast month

    Why Analysts Are Bullish on Aphria

    Aphria (APHQF) is also doing its part to penetrate markets where medical cannabis (SEED-TSE) is legal. On May 16, the company signed an exclusive agreement to supply medical cannabis in Columbia. The agreement is with Colcanna SAS, which has the license to import and distribute medical cannabis in the country.

  • Analysts Are More Bearish about Cronos Group in May
    Market Realistlast month

    Analysts Are More Bearish about Cronos Group in May

    Cronos Group (CRON) reported its first-quarter earnings on May 15 with sales growth of almost 4.8x. Following the earnings release, the stock fell 5% on May 15 and fell another 3.4% on May 16 to 7.7 Canadian dollars. The company cut its recommendation to “sell” from “hold” but raised the price target to 6.5 Canadian dollars from 6 Canadian dollars.

  • CNW Grouplast month

    Aphria's German subsidiary, Nuuvera Deutschland, acquires interest in Berlin-based Shöneberg Hospital

    LEAMINGTON, ON , May 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its wholly-owned subsidiary Nuuvera Deutschland GmbH ("Deutschland") has acquired a 25.1% interest in Berlin -based Schöneberg Hospital ("Schöneberg" or the "Hospital"). The acquisition facilitates Deutschland's long-term strategy to educate German physicians and patients and advance evidence that supports the effectiveness of medical cannabinoids.

  • CNW Grouplast month

    Aphria selects Great North Distributors, a Canadian subsidiary of Southern Glazer's Wine & Spirits, for Canada-wide distribution of adult-use cannabis

    LEAMINGTON , ON and TORONTO , May 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) and Great North Distributors, Inc. ("Great North Distributors"), a wholly-owned Canadian subsidiary of Southern Glazer's Wine & Spirits ("Southern Glazer's") dedicated to the representation of cannabis products, are pleased to announce today that they have signed an agreement for Great North Distributors to serve as exclusive manufacturer's representative for Aphria's adult-use cannabis products throughout Canada , following the legalization of recreational cannabis for adult-use anticipated later this year.

  • Business Wirelast month

    Aphria Selects Great North Distributors, a Canadian Subsidiary of Southern Glazer’s Wine & Spirits, for Canada-Wide Distribution of Adult-Use Cannabis

    Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) and Great North Distributors, Inc. (“Great North Distributors”), a wholly-owned Canadian subsidiary of Southern Glazer’s Wine & Spirits (“Southern Glazer’s”) dedicated to the representation of cannabis products, are pleased to announce today that they have signed an agreement for Great North Distributors to serve as exclusive manufacturer’s representative for Aphria’s adult-use cannabis products throughout Canada, following the legalization of recreational cannabis for adult-use anticipated later this year.

  • CNW Grouplast month

    Aphria signs exclusive agreement with Colombia-based Colcanna SAS to supply medical cannabis in Colombia

    LEAMINGTON , ON, May 16, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed an exclusive supply agreement with Colcanna SAS ("Colcanna") a Colombia -based pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical cannabis, medical products and derivatives in Colombia . "We see tremendous potential for medical cannabis in several emerging markets, including Colombia ," said Vic Neufeld , CEO of Aphria.

  • Cronos Group Stock Falls ~5% after Q1 Earnings Release
    Market Realistlast month

    Cronos Group Stock Falls ~5% after Q1 Earnings Release

    Cronos Group (CRON) reported its first-quarter earnings on May 15. The company’s sales rose almost 4.8 times year-over-year to 2.9 million Canadian dollars from 0.5 million Canadian dollars in the first quarter of 2017. Sequentially, sales grew 83% from 1.3 million Canadian dollars.